HEADER HYDROLASE/HYDROLASE INHIBITOR 21-DEC-99 1DOJ
TITLE CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN*RWJ-51438 COMPLEX AT 1.7 A
CAVEAT 1DOJ NAG A 250 HAS WRONG CHIRALITY AT ATOM C2 NAG A 250 HAS WRONG
CAVEAT 2 1DOJ CHIRALITY AT ATOM C3 NAG A 250 HAS WRONG CHIRALITY AT ATOM
CAVEAT 3 1DOJ C4
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: ALPHA-THROMBIN;
COMPND 3 CHAIN: A;
COMPND 4 EC: 3.4.21.5;
COMPND 5 MOL_ID: 2;
COMPND 6 MOLECULE: HIRUGEN;
COMPND 7 CHAIN: B;
COMPND 8 FRAGMENT: FRAGMENT OF HIRUDIN;
COMPND 9 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 CELLULAR_LOCATION: PLASMA;
SOURCE 6 MOL_ID: 2;
SOURCE 7 SYNTHETIC: YES;
SOURCE 8 OTHER_DETAILS: HIRUGEN, COMES FROM HIRUDIN
KEYWDS THROMBIN, SERINE PROTEASE, ENZYME INHIBITION, HYDROLASE-HYDROLASE
KEYWDS 2 INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR R.RECACHA,M.J.COSTANZO,B.E.MARYANOFF,M.CARSON,L.DELUCAS,
AUTHOR 2 D.CHATTOPADHYAY
REVDAT 7 30-OCT-24 1DOJ 1 REMARK
REVDAT 6 13-MAR-24 1DOJ 1 COMPND SOURCE HETSYN
REVDAT 5 29-JUL-20 1DOJ 1 CAVEAT COMPND REMARK HETNAM
REVDAT 5 2 1 LINK SITE
REVDAT 4 13-JUL-11 1DOJ 1 VERSN
REVDAT 3 24-FEB-09 1DOJ 1 VERSN
REVDAT 2 01-APR-03 1DOJ 1 JRNL
REVDAT 1 03-NOV-00 1DOJ 0
JRNL AUTH R.RECACHA,M.J.COSTANZO,B.E.MARYANOFF,M.CARSON,L.DELUCAS,
JRNL AUTH 2 D.CHATTOPADHYAY
JRNL TITL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH RWJ-51438
JRNL TITL 2 AT 1.7 A: UNUSUAL PERTURBATION OF THE 60A-60I INSERTION
JRNL TITL 3 LOOP.
JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 56 1395 2000
JRNL REFN ISSN 0907-4449
JRNL PMID 11053836
JRNL DOI 10.1107/S0907444900010763
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH X.QIU,K.P.PADMANABHAN,V.E.CARPEROS,A.TULINSKY,T.KLINE,
REMARK 1 AUTH 2 J.M.MARAGANORE,J.W.FENTON II
REMARK 1 TITL STRUCTURE OF THE HIRULOG 3-THROMBIN COMPLEX AND NATURE OF
REMARK 1 TITL 2 THE S' SUBSITES OF SUBSTRATES AND INHIBITORS
REMARK 1 REF BIOCHEMISTRY V. 31 11689 1992
REMARK 1 REFN ISSN 0006-2960
REMARK 1 REFERENCE 2
REMARK 1 AUTH J.H.MATTHEWS,R.KRISHNAN,M.J.COSTANZO,B.E.MARYANOFF,
REMARK 1 AUTH 2 A.TULINSKY
REMARK 1 TITL CRYSTAL STRUCTURE OF THROMBIN WITH THIAZOLE-CONTAINING
REMARK 1 TITL 2 INHIBITORS: PROBES OF THE S1' BINDING SITE
REMARK 1 REF BIOPHYS.J. V. 71 2830 1996
REMARK 1 REFN ISSN 0006-3495
REMARK 1 REFERENCE 3
REMARK 1 AUTH W.BODE,D.TURK,A.KARSHIKOV
REMARK 1 TITL THE REFINED 1.9-A X-RAY CRYSTAL STRUCTURE OF D-PRO-PHE-ARG
REMARK 1 TITL 2 CHLOROMETHYLKETONE-INHIBITED HUMAN ALPHA-THROMBIN: STRUCTURE
REMARK 1 TITL 3 ANALYSIS, OVERALL STRUCTURE, ELECTROSTATIC PROPERTIES,
REMARK 1 TITL 4 DETAILED ACTIVE-SITE GEOMETRY, AND STRUCTURE-FUNCTION
REMARK 1 TITL 5 RELATIONSHIPS
REMARK 1 REF PROTEIN SCI. V. 1 426 1992
REMARK 1 REFN ISSN 0961-8368
REMARK 2
REMARK 2 RESOLUTION. 1.70 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : X-PLOR 3.851
REMARK 3 AUTHORS : BRUNGER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 3.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1520225.350
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.2
REMARK 3 NUMBER OF REFLECTIONS : 33357
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.174
REMARK 3 FREE R VALUE : 0.217
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000
REMARK 3 FREE R VALUE TEST SET COUNT : 3322
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 56.40
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3311
REMARK 3 BIN R VALUE (WORKING SET) : 0.2760
REMARK 3 BIN FREE R VALUE : 0.2980
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 3670
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2452
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 58
REMARK 3 SOLVENT ATOMS : 349
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 16.20
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.50
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 1.02000
REMARK 3 B22 (A**2) : -1.45000
REMARK 3 B33 (A**2) : 0.43000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18
REMARK 3 ESD FROM SIGMAA (A) : 0.13
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.400
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.30
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.610
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 1.400 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.060 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 2.420 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.480 ; 2.500
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : INH3.PARAM
REMARK 3 PARAMETER FILE 3 : ION.PARAM
REMARK 3 PARAMETER FILE 4 : NAG.PARAM
REMARK 3 PARAMETER FILE 5 : NULL
REMARK 3 PARAMETER FILE 6 : NULL
REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO
REMARK 3 TOPOLOGY FILE 2 : TOPH19.SOL
REMARK 3 TOPOLOGY FILE 3 : INH2.TOP
REMARK 3 TOPOLOGY FILE 4 : NAG.TOP
REMARK 3 TOPOLOGY FILE 5 : SULF.TOP
REMARK 3 TOPOLOGY FILE 6 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: THE BIJVOET DIFFERENCES WERE USED IN
REMARK 3 PHASING
REMARK 4
REMARK 4 1DOJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JAN-00.
REMARK 100 THE DEPOSITION ID IS D_1000010249.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 04-MAR-98
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 126549
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660
REMARK 200 RESOLUTION RANGE LOW (A) : 99.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 87.1
REMARK 200 DATA REDUNDANCY : 5.000
REMARK 200 R MERGE (I) : 0.04000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : 87.1
REMARK 200 DATA REDUNDANCY IN SHELL : 3.00
REMARK 200 R MERGE FOR SHELL (I) : 0.20000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.21
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.75 SODIUM ACETATE, 0.01% (W/V), 20%
REMARK 280 POLYETHYLENE GLYCOL 4000 (W/V), PH 6.5, VAPOR DIFFUSION, HANGING
REMARK 280 DROP, TEMPERATURE 295.0K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X+1/2,Y+1/2,-Z
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 31.49100
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.76050
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.49100
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.76050
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 14L
REMARK 465 ARG A 15
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 THR A 1H OG1 CG2
REMARK 470 PHE A 1G CG CD1 CD2 CE1 CE2 CZ
REMARK 470 ASP A 14M CB CG OD1 OD2
REMARK 470 GLU A 247 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PHE A 1G -15.98 -144.81
REMARK 500 PHE A 7 -86.97 -132.94
REMARK 500 ASN A 60G 84.37 -163.05
REMARK 500 HIS A 71 -57.54 -130.71
REMARK 500 ILE A 79 -57.99 -120.15
REMARK 500 GLU A 97A -69.60 -107.42
REMARK 500 SER A 214 -69.79 -109.61
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 NA A 301 NA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 LYS A 169 O
REMARK 620 2 THR A 172 O 63.8
REMARK 620 3 ILE A 174 O 143.0 91.4
REMARK 620 4 HOH A 684 O 121.6 164.7 89.8
REMARK 620 N 1 2 3
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 NA A 300 NA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ARG A 221A O
REMARK 620 2 LYS A 224 O 90.4
REMARK 620 3 HOH A 531 O 157.7 68.3
REMARK 620 4 HOH A 595 O 90.0 93.4 85.2
REMARK 620 5 HOH A 713 O 95.1 81.3 88.2 172.7
REMARK 620 6 HOH A 714 O 110.8 158.8 90.8 88.3 94.8
REMARK 620 N 1 2 3 4 5
REMARK 630
REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE THROMBIN INHIBITOR
REMARK 630 MOLECULE NAME: N-METHYL-D-PHENYLALANYL-N-{(1S)-4-CARBAMIMIDAMIDO-1-
REMARK 630 [(6-CARBOXY-1,3-BENZOTHIAZOL-2-YL)CARBONYL]BUTYL}-L-PROLINAMIDE
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 630
REMARK 630 M RES C SSSEQI
REMARK 630 1Z0 A 401
REMARK 630 SOURCE: NULL
REMARK 630 TAXONOMY: NULL
REMARK 630 SUBCOMP: ZAE PRO AR2
REMARK 630 DETAILS: NULL
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1ABJ RELATED DB: PDB
REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH D-PHE-PRO-ARG
REMARK 900 CHLOROMETHYLKETONE (PPACK)
DBREF 1DOJ A 1H 247 UNP P00734 THRB_HUMAN 328 622
DBREF 1DOJ B 355 365 UNP P09945 HIRV2_HIRME 62 72
SEQRES 1 A 295 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO
SEQRES 2 A 295 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG
SEQRES 3 A 295 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG ILE VAL GLU
SEQRES 4 A 295 GLY SER ASP ALA GLU ILE GLY MET SER PRO TRP GLN VAL
SEQRES 5 A 295 MET LEU PHE ARG LYS SER PRO GLN GLU LEU LEU CYS GLY
SEQRES 6 A 295 ALA SER LEU ILE SER ASP ARG TRP VAL LEU THR ALA ALA
SEQRES 7 A 295 HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS ASN PHE THR
SEQRES 8 A 295 GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS HIS SER ARG
SEQRES 9 A 295 THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SER MET LEU
SEQRES 10 A 295 GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN TRP ARG GLU
SEQRES 11 A 295 ASN LEU ASP ARG ASP ILE ALA LEU MET LYS LEU LYS LYS
SEQRES 12 A 295 PRO VAL ALA PHE SER ASP TYR ILE HIS PRO VAL CYS LEU
SEQRES 13 A 295 PRO ASP ARG GLU THR ALA ALA SER LEU LEU GLN ALA GLY
SEQRES 14 A 295 TYR LYS GLY ARG VAL THR GLY TRP GLY ASN LEU LYS GLU
SEQRES 15 A 295 THR TRP THR ALA ASN VAL GLY LYS GLY GLN PRO SER VAL
SEQRES 16 A 295 LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU ARG PRO VAL
SEQRES 17 A 295 CYS LYS ASP SER THR ARG ILE ARG ILE THR ASP ASN MET
SEQRES 18 A 295 PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY LYS ARG GLY
SEQRES 19 A 295 ASP ALA CYS GLU GLY ASP SER GLY GLY PRO PHE VAL MET
SEQRES 20 A 295 LYS SER PRO PHE ASN ASN ARG TRP TYR GLN MET GLY ILE
SEQRES 21 A 295 VAL SER TRP GLY GLU GLY CYS ASP ARG ASP GLY LYS TYR
SEQRES 22 A 295 GLY PHE TYR THR HIS VAL PHE ARG LEU LYS LYS TRP ILE
SEQRES 23 A 295 GLN LYS VAL ILE ASP GLN PHE GLY GLU
SEQRES 1 B 11 ASP PHE GLU GLU ILE PRO GLU GLU TYS LEU GLN
MODRES 1DOJ ASN A 60G ASN GLYCOSYLATION SITE
MODRES 1DOJ TYS B 363 TYR O-SULFO-L-TYROSINE
HET TYS B 363 16
HET 1Z0 A 401 42
HET NAG A 250 14
HET NA A 300 1
HET NA A 301 1
HETNAM TYS O-SULFO-L-TYROSINE
HETNAM 1Z0 N-METHYL-D-PHENYLALANYL-N-{(1S)-4-CARBAMIMIDAMIDO-1-
HETNAM 2 1Z0 [(6-CARBOXY-1,3-BENZOTHIAZOL-2-YL)CARBONYL]BUTYL}-L-
HETNAM 3 1Z0 PROLINAMIDE
HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE
HETNAM NA SODIUM ION
HETSYN 1Z0 RWJ-51438
HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA-
HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO-
HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE
FORMUL 2 TYS C9 H11 N O6 S
FORMUL 3 1Z0 C29 H35 N7 O5 S
FORMUL 4 NAG C8 H15 N O6
FORMUL 5 NA 2(NA 1+)
FORMUL 7 HOH *349(H2 O)
HELIX 1 1 PHE A 7 SER A 11 5 5
HELIX 2 3 ALA A 55 LEU A 59 1 5
HELIX 3 5 ASP A 125 LEU A 130 1 9
HELIX 4 6 GLU A 164 SER A 171 1 8
HELIX 5 8 VAL A 231 PHE A 245 1 15
SHEET 1 A 7 SER A 20 ASP A 21 0
SHEET 2 A 7 GLN A 156 PRO A 161 -1 N VAL A 157 O SER A 20
SHEET 3 A 7 LYS A 135 GLY A 140 -1 N GLY A 136 O LEU A 160
SHEET 4 A 7 PRO A 198 LYS A 202 -1 O PRO A 198 N THR A 139
SHEET 5 A 7 TRP A 207 TRP A 215 -1 N TYR A 208 O MET A 201
SHEET 6 A 7 GLY A 226 HIS A 230 -1 N PHE A 227 O TRP A 215
SHEET 7 A 7 MET A 180 ALA A 183 -1 O PHE A 181 N TYR A 228
SHEET 1 B 7 GLN A 30 ARG A 35 0
SHEET 2 B 7 GLU A 39 LEU A 46 -1 O GLU A 39 N ARG A 35
SHEET 3 B 7 TRP A 51 THR A 54 -1 N LEU A 53 O SER A 45
SHEET 4 B 7 ALA A 104 LEU A 108 -1 N ALA A 104 O THR A 54
SHEET 5 B 7 LYS A 81 ILE A 90 -1 N GLU A 86 O LYS A 107
SHEET 6 B 7 LEU A 64 ILE A 68 -1 O LEU A 64 N LEU A 85
SHEET 7 B 7 GLN A 30 ARG A 35 -1 O MET A 32 N ARG A 67
SSBOND 1 CYS A 1 CYS A 122 1555 1555 2.03
SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.03
SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.03
SSBOND 4 CYS A 191 CYS A 220 1555 1555 2.03
LINK ND2 ASN A 60G C1 NAG A 250 1555 1555 1.46
LINK OG SER A 195 C4 1Z0 A 401 1555 1555 1.42
LINK C GLU B 362 N TYS B 363 1555 1555 1.33
LINK C TYS B 363 N LEU B 364 1555 1555 1.33
LINK O LYS A 169 NA NA A 301 1555 1555 2.81
LINK O THR A 172 NA NA A 301 1555 1555 2.74
LINK O ILE A 174 NA NA A 301 1555 1555 2.73
LINK O ARG A 221A NA NA A 300 1555 1555 2.40
LINK O LYS A 224 NA NA A 300 1555 1555 2.47
LINK NA NA A 300 O HOH A 531 1555 1555 2.63
LINK NA NA A 300 O HOH A 595 1555 1555 2.61
LINK NA NA A 300 O HOH A 713 1555 1555 2.47
LINK NA NA A 300 O HOH A 714 1555 1555 2.51
LINK NA NA A 301 O HOH A 684 1555 1555 2.88
CISPEP 1 SER A 36A PRO A 37 0 -0.07
CRYST1 62.982 117.521 47.989 90.00 90.00 90.00 P 21 21 2 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015878 0.000000 0.000000 0.00000
SCALE2 0.000000 0.008509 0.000000 0.00000
SCALE3 0.000000 0.000000 0.020838 0.00000